LONDON, January 23 /PRNewswire/ -- Dr Judith Bryans, Director of The Dairy Council said: "We are pleased to see that the government report on obesity released today highlighted both food and physical activity. Very often the physical activity aspect of obesity is ignored, but in order to adequately address the issue of obesity both aspects must be given equal importance. Although food is part of the equation, we must be careful to ensure that the public is educated about portion sizes and the importance of eating from all of the food groups, including dairy, in order to stay healthy as well as achieve and maintain a healthy weight."

http://www.milk.co.uk

SAO PAULO, Brazil, January 23 /PRNewswire/ --

The Brazilian Sugar Cane Industry Association (UNICA) welcomes the proposal by the European Commission released today as a sensible approach to meet the ambitious binding targets agreed on by heads of government from the European Union last March. The draft directive paves the way for biofuels to make up at least 10% of transport fuels in Europe by 2020, which goes a long way towards the development and consolidation of a biofuels market in Europe.

BRUSSELS, January 23 /PRNewswire/ -- Today's Commission proposal for 20% renewable energy by 2020 paves the way for a massive expansion of wind energy in the 27 Member States and a new energy future for Europe. It proposes a stable and flexible EU framework in which Member States keep control of their renewable energy policies through successful national support systems. In addition, cross-border transfer of guarantees of origin can only take place where Member States have met or exceeded their interim targets. For the European Wind Energy Association (EWEA), these two elements are crucial for maintaining investor confidence and encouraging substantial investments in green electricity.

HALIFAX, Canada, January 23 /PRNewswire/ -- ImmunoVaccine Technologies Inc. (IVT) announced today that it has met with Health Canada's regulatory affairs division, the Biologics and Genetic Therapies Directorate, to discuss requirements for a Phase I clinical trial application. For Phase I human clinical trials, IVT plans to combine novel antigens with its vaccine-enhancement technology, the VacciMax(R) platform.

"We are seeing impressive pre-clinical results with the VacciMax(R) platform," said Dr. Randal Chase, president and CEO of IVT. "The comments from the Biologics and Genetic Therapies Directorate are much appreciated because they give us direction as we proceed with our clinical development in Canada," said Dr. Chase.

REDWOOD CITY, California, January 23 /PRNewswire/ --

Codexis, Inc., a private biotechnology company and leading developer of clean manufacturing processes, today announced the opening of Codexis Laboratories Hungary Kft (CLH) in Budapest.

IRVINE, California and LONDON, January 23 /PRNewswire/ --

- Logibanque Solution Helps Groupe Moniteur Quickly Evolve to SaaS Offering

Endeavors Technologies, the pioneer in application streaming and virtualization technology, and its parent company, Tadpole Technology plc, today announced Wallace Systems has incorporated AppExpress into its Logibanque software distribution and management system. Wallace Systems has implemented its first large-scale deployment of Logibanque at Groupe Moniteur in France, enabling Groupe Moniteur to immediately offer its extensive information catalogs via a web-based system and avoid a time consuming, expensive move to web 2.0 technologies.